Columvi (glofitamab-gxbm) - Roche
Efficacy and Safety of glofitamab Sequencing Strategies Following Chimeric Antigen Receptor T-Cell Therapy Failure in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review and Subgroup Meta-Analysis (ESMO-IO 2026) - Oct 25, 2026 - Abstract #182P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available 
CAR T-Cell Therapy • Retrospective data • Review • B Cell Lymphoma • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
https://cslide.ctimeetingtech.com/immuno2026/attendee/confcal/print/presentation/795
 
Hadeel K. Albaoni
 
Oct 25, 2026
 
Prev Next